CRH Cuts FY26 Net Income Guide to $3.1B-$3.3B, Launches $6B Buyback
CRH is trading near its 52-week low of $78.62 (4.9% above the low).
Summary
CRH posted flat Q3 Adjusted EBITDA of $2.7B on $11.4B revenue and cut full-year net income guidance to $3.1B-$3.3B, while authorizing a new $6B share buyback through 2030 and raising the dividend 5%.
Key Events · Earnings and Guidance · CRH
-
Q3 Results: Flat EBITDA, Lower Net Income
Total revenues rose 3% to $11.4B, but Adjusted EBITDA was flat at $2.7B and net income fell 22% to $1.2B, including a $178M impairment in the Philippines reporting unit.
-
Full-Year Guidance Cut Sharply
FY26 net income guidance drops to $3.1B-$3.3B from $3.9B-$4.1B and Adjusted EBITDA to $7.8B-$8.0B from $8.1B-$8.5B; diluted EPS guidance falls to $4.63-$4.85 from $5.60-$6.05.
-
New $6B Buyback Through 2030
The board authorized repurchases of up to $6B expiring at the end of 2030, alongside a 5% dividend increase to $0.39 per share payable December 9, 2026.
-
Velocity Program Targets $400M Savings
The two-year operating-model overhaul is expected to deliver ~$400M of annual run-rate benefits by end-2028 against ~$400M of total non-routine costs; $49M has been recognized so far.
Analysis · CRH · Manufacturing
The operating line stalled in the third quarter: revenue rose 3% to $11.4B, yet Adjusted EBITDA held at $2.7B as cost inflation and weak residential demand offset pricing and acquisitions. More consequential is the full-year reset. Net income guidance falls to $3.1B-$3.3B from $3.9B-$4.1B, and Adjusted EBITDA to $7.8B-$8.0B from $8.1B-$8.5B, reflecting the earlier-than-expected Arcosa close, a $178M Philippines impairment and a softer residential market. Against that backdrop, the board authorized a new buyback of up to $6B through 2030 and raised the dividend 5% — a signal that management views the selloff (shares near the 52-week low of $78.62) as overdone relative to cash generation. The swing factor is the Velocity program: ~$400M of annual run-rate savings by end-2028, but ~$400M of implementation cost first.
How filings like this one have moved
In the 30 days to Nov 12, 2026, 47.3% of the 1873 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.17%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CRH was trading at $82.50 on NYSE in the Manufacturing sector, with a market capitalization of approximately $57.6B. The 52-week trading range was $78.62 to $131.55. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.